Search research articles
Contact Us
Filters
Showing results (161-170 of 176) with videos related to
Page
of 18
Sort By:
Mycoses
|
September 15, 2019
Ibrutinib-associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: An observational study
Rosa Ruchlemer, Ronen Ben-Ami, Maskit Bar-Meir, et al.
The Lancet. Haematology
|
June 6, 2024
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial
Jillian R Gunther, Jie Xu, Manoop S Bhutani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2023
Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium
Yucai Wang, Preetesh Jain, Frederick L Locke, et al.
Cell Reports. Medicine
|
November 17, 2022
A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphoma
Johannes F Fahrmann, Neeraj Y Saini, Chang Chia-Chi, et al.
Nature Communications
|
October 7, 2024
Author Correction: Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma
Shaojun Zhang, Vivian Changying Jiang, Guangchun Han, et al.
Nature Communications
|
May 18, 2021
Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma
Shaojun Zhang, Vivian Changying Jiang, Guangchun Han, et al.
Blood Advances
|
March 20, 2020
Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL
Preetesh Jain, Shaojun Zhang, Rashmi Kanagal-Shamanna, et al.
American Journal of Hematology
|
April 3, 2020
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients
Shuangtao Zhao, Rashmi Kanagal-Shamanna, Lucy Navsaria, et al.
The Lancet. Oncology
|
January 25, 2022
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial
Michael L Wang, Preetesh Jain, Shuangtao Zhao, et al.
Blood Cancer Discovery
|
May 9, 2022
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma
Neeraj Y Saini, David M Swoboda, Uri Greenbaum, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 176) with videos related to
Sort By:
Page
of 18
Mycoses
|
September 15, 2019
Ibrutinib-associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: An observational study
Rosa Ruchlemer, Ronen Ben-Ami, Maskit Bar-Meir, et al.
The Lancet. Haematology
|
June 6, 2024
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial
Jillian R Gunther, Jie Xu, Manoop S Bhutani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2023
Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium
Yucai Wang, Preetesh Jain, Frederick L Locke, et al.
Cell Reports. Medicine
|
November 17, 2022
A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphoma
Johannes F Fahrmann, Neeraj Y Saini, Chang Chia-Chi, et al.
Nature Communications
|
October 7, 2024
Author Correction: Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma
Shaojun Zhang, Vivian Changying Jiang, Guangchun Han, et al.
Nature Communications
|
May 18, 2021
Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma
Shaojun Zhang, Vivian Changying Jiang, Guangchun Han, et al.
Blood Advances
|
March 20, 2020
Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL
Preetesh Jain, Shaojun Zhang, Rashmi Kanagal-Shamanna, et al.
American Journal of Hematology
|
April 3, 2020
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients
Shuangtao Zhao, Rashmi Kanagal-Shamanna, Lucy Navsaria, et al.
The Lancet. Oncology
|
January 25, 2022
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial
Michael L Wang, Preetesh Jain, Shuangtao Zhao, et al.
Blood Cancer Discovery
|
May 9, 2022
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma
Neeraj Y Saini, David M Swoboda, Uri Greenbaum, et al.
Page
of 18